Overall Risk of Myopericarditis Low After COVID-19 Vaccine
TUESDAY, April 12, 2022 (HealthDay News) — Myopericarditis is rare following COVID-19 vaccination, with an overall incidence not differing significantly for those receiving COVID-19 vaccines or non-COVID-19 vaccines, according to a review published online April 11 in The Lancet Respiratory Medicine.
Ryan Ruiyang Ling, from the Yong Loo Lin School of Medicine in Singapore, and colleagues...
Learn MoreDMARDs Not Linked to Alzheimer Risk for Seniors With RA
TUESDAY, April 12, 2022 (HealthDay News) — For patients with rheumatoid arthritis aged 65 years and older, the risk of Alzheimer disease and related dementia (ADRD) does not differ with tofacitinib, tocilizumab, or tumor necrosis factor (TNF) inhibit…
Learn MoreParental Cancer Tied to Poorer Health Outcomes in Children
TUESDAY, April 12, 2022 (HealthDay News) — Parental cancer is associated with school absenteeism, medical care unaffordability, increased health care use, and poor mental health among children, according to a study published online April 11 in JAMA Pediatrics.
Zhiyuan Zheng, Ph.D., from the American Cancer Society in Atlanta, and colleagues examined associations of parental cancer with...
Learn MoreSGLT2 Inhibitors Reduce Heart Failure Hospitalization
TUESDAY, April 12, 2022 (HealthDay News) — For patients with heart failure, sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce hospitalization for heart failure and cardiovascular death, but increase the risk of genital infections, according to…
Learn MorePhiladelphia Becomes First U.S. City to Bring Back Indoor Mask Mandate
TUESDAY, April 12, 2022 (HealthDay News) — Faced with rising COVID-19 case counts, Philadelphia has announced that it will reinstate an indoor mask mandate next week.City officials announced the change on Monday, as COVID-19 cases have climbed across…
Learn MoreNew Drug Halves Death Rate in Those With Severe COVID, Maker Claims
TUESDAY, April 12, 2022 (HealthDay News) — An experimental medication for critically ill COVID-19 patients appears to work so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emergency use authori…
Learn MoreCould Some Rheumatoid Arthritis Meds Help Lower Alzheimer’s Risk?
TUESDAY, April 12, 2022 (HealthDay News) — In their search for a drug to prevent Alzheimer’s disease, scientists are taking a look at certain rheumatoid arthritis drugs.Preliminary findings suggest that a type of rheumatoid arthritis drug known as TN…
Learn MoreHealth Highlights: April 12, 2022
New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug’s maker announced Monday it has stopped its clinical trial early and will apply for emer…
Learn MoreStudy Finds Just One Dose of HPV Vaccine May Be Enough
TUESDAY, April 12, 2022 (HealthDay News) — A single dose of human papillomavirus (HPV) vaccine provides as much protection against cervical cancer as the standard three-dose regimen, a new study finds.”These findings are a game-changer that may subst…
Learn MoreHalf of World’s People Suffer From Headaches
TUESDAY, April 12, 2022 (HealthDay News) — If you suffer from headaches, you have plenty of company. Headaches afflict half of the world’s population, and women are more likely to get them than men, a new paper says.”We found that the prevalence of …
Learn More